Evolus Advances Mid-Face Filler Toward FDA Approval
Evolus has submitted the final module of its PMA application to the FDA for Evolysse Sculpt, an injectable HA gel for mid-face volume restoration.
Evolus has submitted the final module of its PMA application to the FDA for Evolysse Sculpt, an injectable HA gel for mid-face volume restoration.
The nearly 2,500-patient study found no benefit from drain use, including among patients considered at higher risk for complications.